Skip to main content
Veterinary Medicines

Program 133 mg Suspension zum Eingeben für Katzen

Not authorised
  • Lufenuron

Product identification

Medicine name:
Program 133 mg Suspension zum Eingeben für Katzen
Active substance:
  • Lufenuron
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lufenuron
    133.00
    milligram(s)
    /
    1.00
    Ampoule
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53BC01
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00281
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/01/2021
Updated on: 3/05/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/01/2021
Updated on: 3/05/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/01/2021
Updated on: 3/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."